Amedisys Inc. (AMED) Company Profile & Statistics

Amedisys Inc.
AMED
(Nasdaq - US)
Closed
95.97
+0.58 (+0.60%)
in:usd•As of: Nov 05, 2024 15:59 UTC -5
Open
95.28
High
95.97
Low
95.28

About Amedisys Inc.

CEO

Richard Ashworth

Headquarters

3854 american way, suite a

baton rouge, la 70816, united states

Auditor

KPMG LLP

Employees

19,000

Share Holders

458

Website

www.amedisys.com

Industry

medical or nursing services

Sector

health services

Company Overview

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).

Amedisys Inc. Statistics

Valuation Measures

Market Capitalization ²	3.14B
Enterprise Value	3.37B
Enterprise Value/EBITDA (ttm)	15.36
Price to Earnings Ratio (ttm)	22.36
Price to Book (mrq)	2.65
Price to Sales (ttm)	1.37
Price to Cash (ytd)	15.62

Profitability

Gross Margin (ttm)	44.02%
Operating Margin (ttm)	6.14%
Profit Margin (ttm)	4.01%
Return on Equity (ttm)	12.39%
Return on Invested Capital (ttm)	6.14%
Return on Assets (ttm)	6.78%

Income Statement

Revenue (ttm)	2.29B
Revenue Per Share (ttm)	69.93
Gross Profit (ttm)	1.01B
EBITDA (ttm)³	219.62M
Net Income Avi to Common (ttm)	91.98M
Diluted EPS (ttm)	2.80

Share Statistics

Beta (5Y Monthly)	0.78
52-Week Change	4.04%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	32.74M
Dividend Yield	0.00%
Float ⁴	32.15M
% Held by Insiders	1.80%
% Held by Institutions	94.36%

Balance Sheet

Total Cash (mrq)	157.36M
Total Cash Per Share (mrq)	4.81
Total Debt (mrq)	389.19M
Total Debt/Equity (mrq)	33.01%
Current Ratio (mrq)	1.16%
Quick Ratio (mrq)	1.16%
Book Value Per Share (mrq)	36.01

Cash Flow

Operating Cash Flow Per Share (ytd)	1.38
Free Cash Flow (ytd)	41.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Amedisys Inc.

Trade With A Regulated Broker